Engineered peptide PLG0206 overcomes limitations of a challenging antimicrobial drug class | Zendy

David B. Huang | Zendy; Kimberly M. Brothers | Zendy; Jonathan B. Mandell | Zendy; Masashi Taguchi | Zendy; Peter G. Alexander | Zendy; Dana M. Parker | Zendy; Dean L. Shinabarger | Zendy; Chris M. Pillar | Zendy; Ian Morrissey | Zendy; Stephen Hawser | Zendy; Parviz Ghahramani | Zendy; Despina Dobbins | Zendy; Nicholas Pachuda | Zendy; Ronald C. Montelaro | Zendy; Jonathan D. Steckbeck | Zendy; Kenneth L. Urish | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Engineered peptide PLG0206 overcomes limitations of a challenging antimicrobial drug class

Author(s) -

David B. Huang,

Kimberly M. Brothers,

Jonathan B. Mandell,

Masashi Taguchi,

Peter G. Alexander,

Dana M. Parker,

Dean L. Shinabarger,

Chris M. Pillar,

Ian Morrissey,

Stephen Hawser,

Parviz Ghahramani,

Despina Dobbins,

Nicholas Pachuda,

Ronald C. Montelaro,

Jonathan D. Steckbeck,

Kenneth L. Urish

Publication year - 2022

Publication title -

plos one

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.99

H-Index - 332

ISSN - 1932-6203

DOI - 10.1371/journal.pone.0274815

Subject(s) - antimicrobial , drug , antibiotics , biofilm , multiple drug resistance , antimicrobial peptides , anti infective agents , peptide , antimicrobial drug , drug development , pharmacokinetics , pharmacology , medicine , biology , computational biology , microbiology and biotechnology , bacteria , biochemistry , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research